Literature DB >> 14965292

Anti-Helicobacter pylori agents. An update.

E M F Muri1, J S Williamson.   

Abstract

Helicobacter pylori infection is the major causative factor of a number of gastric pathologies. Several classes of compounds have been identified as anti-H. pylori agents. Here we provide a review of anti-H. pylori compounds that have recently appeared in the literature, including the guanidino, antibiotics, acetamide, pyrazole and benzimidazole compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14965292     DOI: 10.2174/1389557043487475

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

1.  Synthesis, characterization, anti-ulcer action and molecular docking evaluation of novel benzimidazole-pyrazole hybrids.

Authors:  Abida Noor; Neelum Gul Qazi; Humaira Nadeem; Arif-Ullah Khan; Rehan Zafar Paracha; Fawad Ali; Adil Saeed
Journal:  Chem Cent J       Date:  2017-09-02       Impact factor: 4.215

2.  Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.

Authors:  Ammar Hassanzadeh Keshteli; Floris F van den Brand; Karen L Madsen; Rupasri Mandal; Rosica Valcheva; Karen I Kroeker; Beomsoo Han; Rhonda C Bell; Janis Cole; Thomas Hoevers; David S Wishart; Richard N Fedorak; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

3.  Urinary Metabolomic Approach Provides New Insights into Distinct Metabolic Profiles of Glutamine and N-Carbamylglutamate Supplementation in Rats.

Authors:  Guangmang Liu; Wei Cao; Tingting Fang; Gang Jia; Hua Zhao; Xiaoling Chen; Caimei Wu; Jing Wang
Journal:  Nutrients       Date:  2016-08-04       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.